FMP
NASDAQ
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
2.9 USD
-0.06 (-2.07%)
Valuation Date:
Apr 26, 2024 4:00 PM
Share Price on Valuation Date
$2.9
Stock Beta
1.525
Shares Outstanding
9399400